Insights
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
3 MIN READ
Buprenorphine, a Schedule III controlled substance approved by the U.S. Food and Drug Administration (FDA), is increasingly being considered for pain management in workers' compensation cases. This partial opioid agonist offers a unique profile that balances effective pain relief with a lower risk of abuse and dependence compared to full opioid agonists.
Overcoming Overpayment Risk With FairPay Flex
3 MIN READ
Enhance your specialty bill review workflow with Enlyte's FairPay Flex. Learn how our dedicated team can resolve disputes and streamline processes.
Plugged-In: EV Collision Insights 2024 Year in Review
3 MIN READ
Claims frequency for collision-damaged, repairable battery electric vehicles (BEVs) rose to 2.71% in the U.S. and 3.84% in Canada in 2024, a year-over-year increase of 38% and 34% respectively. CNBC reported that BEVs and hybrids represented 20% of all new U.S. vehicle sales in 2024, and Cox Automotive is predicting that number to climb to 25% in 2025 despite U.S. policy changes that could hinder BEV adoption.
A Guide to Making Specialty Bill Review a Good Fit for You: An Account Manager's Perspective
3 MIN READ
In the complex world of medical bill review, specialty bill review stands out as a powerful tool for achieving significant savings. Chad Countryman, a seasoned account success director at Enlyte, shares his insights on how he coaches clients to understand and implement FairPay Flex effectively.
CSN Collision Conference 2025
The 2025 CSN Collision Conference is an engaging and informative gathering for industry professionals.
Long-Term Catastrophic Assessments
2 MIN READ
Enlyte offers Long-Term Catastrophic Assessments for workers' comp claims. Our comprehensive evaluations help manage complex cases, prevent complications, and ensure proper care.
Third Party Litigation Funding: A Symptom of Deeper Issues in the Legal System
6 MIN READ
In the world of civil litigation, a new player has emerged—third-party litigation funders. These deep-pocketed investors are bankrolling lawsuits they have no direct involvement in, fueling a surge in nuclear verdicts (awards exceeding $10 million) and even thermonuclear verdicts (over $100 million). For workers' compensation and auto insurers, this trend is a ticking time bomb that could lead to skyrocketing claims costs.
Technology and Expertise Driving Better Claims Outcomes
Mitchell simplifies and accelerates claims management and collision repair processes through the broadest range of technology solutions, networks, and partners in the P&C industry.
Learn MoreHelping Injured Workers Get Better, Faster.
Genex helps injured employees return to their jobs in a safe and efficient manner through compassionate case management while reducing total claim cost.
Learn More